Biomarkers of immunoregulatory status in stable liver transplant recipients undergoing weaning of immunosuppressive therapy

Clinical Immunology

Volumn 137, Issue 3, 2010, Pages 337-346

  Millán, Olga ^a,b   Benitez, Carlos ^a   Guillén, David ^a   López, Anna ^a   Rimola, Antoni ^a,b   Sánchez Fueyo, Alberto ^a,b   Brunet, Mercè ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Effector T cell response; Immune response recovery; Immunosuppression minimization; Rejection; Surrogate marker; Withdrawal

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MALE; PHARMACODYNAMICS; PRIORITY JOURNAL; RECIPIENT; RISK ASSESSMENT;

ADULT; AGED; BIOLOGICAL MARKERS; CELL PROLIFERATION; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PHENYLACETATES; PROLIFERATING CELL NUCLEAR ANTIGEN; T-LYMPHOCYTES; TACROLIMUS;

EID: 78149284732     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.08.004     Document Type: Article

References (26)

1. Barten M.J., van Gelder T., Gummert J.F., Boeke K., Shorthouse R., Billingham M.E., Morris R.E. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection. Am. J. Transplant. 2002, 2:719-732.
2. Millán O., Brunet M., Campistol J.M., Faura A., Rojo I., Vidal E., Jiménez O., Vives J., Oppenheimer F., Martorell J. Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil. Clin. Chem. 2003, 49:1891-1899.
3. Ashton-Chess J., Giral M., Soulillou J.P., Brouard S. Can immune monitoring help to minimize immunosuppression in kidney transplantation?. Transpl. Int. 2008, 22:110-119.
4. Patel J., Kobashigawa J.A. Minimization of immunosuppression transplant immunology. Transpl. Immunol. 2008, 20:48-54.
5. Sánchez-Fueyo A., Strom T.B. Immunological tolerance and liver transplantation. J. Hepatol. 2003, 75:1045-1078.
6. Sarwal M.M. Deconvoluting the 'omics' for organ transplantation. Curr. Opin. Organ Transplant. 2009, 14(5):544-551.
7. Kienzl K., Sarg B., Golderer G., Obrist P., Werner E.R., Werner-Felmayer G., Lindner H., Maglione M., Schneeberger S., Margreiter R., Brancacher G. Proteomic profiling of acute cardiac allograft rejection. Transplantation 2009, 88(4):553-560.
8. + T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. Transplantation 2004, 77:1815-1820.
9. + pheripheral blood T cells. Ther. Drug Monit. 2001, 23:354-362.
10. Carpentier A., Conti F., Stenard F., Aoudjehane L., Miroux C., Podevin P., Morales O., Chouzenoux X., Scatton O., Groux H., Auriault C., Calmus Y., Pancre V., Delhem N. Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation. Am. J. Transplant. 2009, 9:2102-2112.
11. Gorelik L., Flavell R.A. Transforming growth factor-beta in T cell biology. Nat. Rev. Immunol. 2002, 2(1):46-53.
12. Pascual J., del Castillo D., Cabello M., Pallardó L., Grinyó J.M., Fernández A.M., Brunet M. Interaction between everolimus and tacrolimus in renal transplant recipients: a pharmacokinetic controlled trial. Transplantation 2010, 89(8):994-1000.
13. Brunet M., Cirera I., Martorell J., Vidal E., Millán O., Jiménez O., Rojo I., Londoño M.C., Rimola A. Sequential determination of pharmacokinetics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. Transplantation 2006, 81:541-5460.
14. Westley I.S., Sallustio B.C., Morris R.G. Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma. Clin. Biochem. 2005, 38(9):824-829.
15. Godoy-Ramirez K., Franck K., Mahdavifar S., Andersson L., Gaines H. Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J. Immunol. Methods 2004, 292(1-2):1-15.
16. Pala P., Hussell T., Openshaw P.J. Flow cytometric measurement of intracellular cytokines. J. Immunol. Methods 2000, 243(1-2):107-124.
17. Sawitzki B., Bushell A., Steger U., Jones M., Risch K., Siepert A., Lehmann M., Schmitt-Knosalla I., Vogt K., Gebuhr I., Wood K., Volk H.D., et al. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am. J. Transplant. 2007, 7(5):1091-1102.
18. Zarkhin V., Sarwal M.M. Microarrays: monitoring for transplant tolerance and mechanistic insights. Clin. Lab. Med. 2008, 28(3):385-410.
19. Martínez-Llordella M., Lozano J.J., Puig-Pey I., Orlando G., Tisone G., Lerut J., Benítez C., Pons J.A., Parrilla P., Ramírez P., Bruguera M., Rimola A., Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 2008, 118(8):2845-2857.
20. Gebauer B.S., Hricik D.E., Atallah A., Bryan K., Riley J., Tary-Lehmann M., Greenspan N.S., Dejelo C., Goehm B.O., Hering B.J., Heeger P.S. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am. J. Transplant. 2002, 2(9):857-866.
21. Li G., Ivaldi F., Bottine L., Koopman G., Manca F. Helper function of cytolytic lymphocytes: switching roles in the immune response. Eur. J. Immunol. 2007, 37(1):66-77.
22. Schnickel G.T., Whiting D., Hsieh G.R., Yun J.J., Fischbein M.P., Fischbein M.C., Fishbein M.C., Yao W., Shfizadeh A., Ardehali A. CD8 lymphocytes are sufficient for the development of chronic rejection. Transplantation 2004, 78(11):1634-1639.
23. Benítez F., Najafian N. Novel noninvasive assays to predict transplantation rejection and tolerance: enumeration of cytokine-producing alloreactive T cells. Clin. Lab. Med. 2008, 28:365-373.
24. Brunet M., Campistol J.M., Diekmann F., Guillen D., Millán O. T-cell function monitoring in stable renal transplant patients treated with sirolimus monotherapy. Mol. Diagn. Ther. 2007, 11(4):247-256.
25. + T cells in the control of inflammation. J. Immunol. 2003, 171:5018-5026.
26. + T cell subsets. J. Leukoc. Biol. 2007, 82(2):335-346.